Trials / Sponsors / Ashvattha Therapeutics, Inc.
Ashvattha Therapeutics, Inc.
Industry · 5 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Study Evaluating Safety & Tolerability of Migaldendranib in Healthy Volunteers Healthy Volunteers | Phase 1 | 2026-01-29 |
| Recruiting | Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers Amyotrophic Lateral Sclerosis (ALS), Parkinson Disease (PD), Alzheimer Disease (AD) | Phase 1 / Phase 2 | 2023-02-02 |
| Active Not Recruiting | Safety, Tolerability and PK of Subcutaneous D-4517.2 in Subjects With Wet AMD or DME Neovascular Age-related Macular Degeneration, Diabetic Macular Edema | Phase 2 | 2022-08-31 |
| Completed | A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of D-4517.2 After Subcutaneous Administrati Neovascular Age-related Macular Degeneration, Diabetic Macular Edema | Phase 1 | 2022-01-11 |
| Terminated | A Study to Evaluate OP-101 (Dendrimer N-acetyl-cysteine) in Severe Coronavirus Disease 2019 (COVID-19) Patient COVID-19 | Phase 2 | 2020-08-11 |